198 related articles for article (PubMed ID: 28602912)
21. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
22. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
24. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
25. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 6-triggered ataxia-telangiectasia mutated kinase activation facilitates epithelial-to-mesenchymal transition in lung cancer by upregulating vimentin expression.
Jiang YN; Ni XY; Yan HQ; Shi L; Lu NN; Wang YN; Li Q; Gao FG
Exp Cell Res; 2019 Aug; 381(2):165-171. PubMed ID: 31100307
[TBL] [Abstract][Full Text] [Related]
27. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P
Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
Gurbuz N; Ashour AA; Alpay SN; Ozpolat B
PLoS One; 2014; 9(9):e110067. PubMed ID: 25268648
[TBL] [Abstract][Full Text] [Related]
29. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-Mesenchymal Transition.
Liu C; Wang H; Li H; Chen X; Wu X; Lu B; Zhang W; Zhou Y; Xiao GG; Gao G
Pancreas; 2019; 48(5):629-635. PubMed ID: 31091208
[TBL] [Abstract][Full Text] [Related]
31. The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial‑to‑mesenchymal transition/epithelial‑to‑mesenchymal transition and increases ionic transporter expression.
Wu Q; Ouyang C; Xie L; Ling Y; Huang T
Int J Mol Med; 2017 Oct; 40(4):1009-1018. PubMed ID: 28849097
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
[TBL] [Abstract][Full Text] [Related]
33. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Hsiao YH; Hsieh MJ; Yang SF; Chen SP; Tsai WC; Chen PN
Phytomedicine; 2019 Sep; 62():152964. PubMed ID: 31153059
[TBL] [Abstract][Full Text] [Related]
34. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.
Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I
Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer.
Kyuno D; Kojima T; Yamaguchi H; Ito T; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
Carcinogenesis; 2013 Jun; 34(6):1232-43. PubMed ID: 23389293
[TBL] [Abstract][Full Text] [Related]
36. USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Yan Q; Wang Z
Oncol Rep; 2014 Oct; 32(4):1451-8. PubMed ID: 25070659
[TBL] [Abstract][Full Text] [Related]
37. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
38. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
Guerra FS; Oliveira RG; Fraga CAM; Mermelstein CDS; Fernandes PD
Sci Rep; 2017 Oct; 7(1):13723. PubMed ID: 29057980
[TBL] [Abstract][Full Text] [Related]
39. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
[TBL] [Abstract][Full Text] [Related]
40. PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells.
Song N; Bai M; Che X; Li Z; Jing W; Li C; Teng Z; Qu X; Liu Y
Med Oncol; 2020 Apr; 37(5):47. PubMed ID: 32277292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]